Peripheral Arterial Disease Therapeutics Market by Treatment Type (Medications, Surgical Treatments), Indication Stage (Asymptomatic, Ischemic Rest Pain, Mild Claudication), End-Users - Global Forecast 2024-2030

Peripheral Arterial Disease Therapeutics Market by Treatment Type (Medications, Surgical Treatments), Indication Stage (Asymptomatic, Ischemic Rest Pain, Mild Claudication), End-Users - Global Forecast 2024-2030


The Peripheral Vascular Devices Market size was estimated at USD 16.24 billion in 2023 and expected to reach USD 18.23 billion in 2024, at a CAGR 12.73% to reach USD 37.58 billion by 2030.

Global Peripheral Vascular Devices Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Peripheral Vascular Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Peripheral Vascular Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Peripheral Vascular Devices Market, highlighting leading vendors and their innovative profiles. These include Amecath, AngioDynamics, Inc., Argon Medical Devices, Inc., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cook Group Incorporated, Esaote S.p.A., Fresenius Medical Care AG & Co. KGaA, FUJIFILM Corporation, Kimal PLC, Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Nipro Corporation, and Siemens AG.

Market Segmentation & Coverage

This research report categorizes the Peripheral Vascular Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Angioplasty Balloons
Angioplasty Stents
Balloon Inflation Devices
Catheters
EVAR Stent Grafts
Guidewires
Hemodynamic Flow Alteration Devices
Inferior Vena Cava Filters
Introducer Sheaths
Plaque Modification Devices
Vascular Closure Devices
End Users
Hospitals
Speciality Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Peripheral Vascular Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Peripheral Vascular Devices Market?
3. What are the technology trends and regulatory frameworks in the Peripheral Vascular Devices Market?
4. What is the market share of the leading vendors in the Peripheral Vascular Devices Market?
5. Which modes and strategic moves are suitable for entering the Peripheral Vascular Devices Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Peripheral Arterial Disease Therapeutics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of peripheral arterial disease with an increasing geriatric population
5.1.1.2. Increasing shift toward unhealthy lifestyles among people globally
5.1.1.3. Growing preference for minimally invasive endovascular procedures
5.1.2. Restraints
5.1.2.1. High cost associated with treatment of peripheral arterial disease
5.1.3. Opportunities
5.1.3.1. Research and development for advanced treatments for peripheral arterial disease
5.1.3.2. Growing product approvals for the treatment of peripheral arterial disease
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals and doctors with proficiency in peripheral arterial disease devices
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Peripheral Arterial Disease Therapeutics Market, by Treatment Type
6.1. Introduction
6.2. Medications
6.3.1. Antihypertensives
6.3.2. Naftidrofuryl Oxalate
6.3.3. Statins
6.3. Surgical Treatments
6.4.1. Angioplasty
6.4.2. Artery Bypass Graft
7. Peripheral Arterial Disease Therapeutics Market, by Indication Stage
7.1. Introduction
7.2. Asymptomatic
7.3. Ischemic Rest Pain
7.4. Mild Claudication
7.5. Moderate/Severe Claudication
7.6. Ulcers/Gangrene
8. Peripheral Arterial Disease Therapeutics Market, by End-Users
8.1. Introduction
8.2. Hospitals
8.3. Specialty Clinics
9. Americas Peripheral Arterial Disease Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Peripheral Arterial Disease Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Peripheral Arterial Disease Therapeutics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Alucent Biomedical Inc.
13.1.3. AnGes, Inc.
13.1.4. AngioDynamics, Inc.
13.1.5. ARCA biopharma, Inc.
13.1.6. B. Braun SE
13.1.7. Becton, Dickinson and Company
13.1.8. BIOTRONIK SE & Co. KG
13.1.9. Boston Scientific Corporation
13.1.10. Cook Group Incorporated
13.1.11. Helixmith Co., Ltd.
13.1.12. Koninklijke Philips N.V.
13.1.13. LeMaitre Vascular, Inc.
13.1.14. Medtronic PLC
13.1.15. Meril Life Sciences Pvt. Ltd.
13.1.16. MicroPort Scientific Corporation
13.1.17. REVA Medical, LLC
13.1.18. Terumo Corporation
13.1.19. Venturis Therapeutics, Inc.
13.1.20. W. L. Gore & Associates, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET DYNAMICS
FIGURE 7. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 8. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2023 VS 2030 (%)
FIGURE 10. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 12. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings